Financial Astrology of Applied Biosystems Group

FINANCIAL ASTROLOGY

First Trade Date for Applied Biosystems Group

Company Name	First Trade Date (yyyy-mm-dd)
Applied Biosystems Group	1980-03-17

Company Name	Symbol
Applied Biosystems Group	ABI
History and Business of Company (this information may include date of incorporation)
Applera Corporation conducts business through three business segments, which are described below. Throughout this report, terms such as "Applera," "we," "us," or "our" may be used to refer to Applera Corporation. Applied Biosystems Group. Our Applied Biosystems Group, which we refer to as "Applied Biosystems" throughout this report, is engaged principally in the development, manufacture, sale, and service of instrument-based systems, reagents, and software, and the provision of contract services, for life science and related applications. A description of this business segment and developments during our 2003 fiscal year is set forth below in this Item 1 under the heading "Applied Biosystems Group Business." Celera Genomics Group. Our Celera Genomics Group, which we refer to as "Celera Genomics" throughout this report, is engaged principally in integrating advanced technologies to discover and develop new therapeutics. Celera Genomics intends to leverage its capabilities in proteomics, bioinformatics, and genomics to identify and validate drug targets and to discover and develop novel therapeutic candidates. A description of this business segment and developments during our 2003 fiscal year is set forth below in this Item 1 under the heading "Celera Genomics Group Business." Celera Diagnostics, a 50/50 Joint Venture between Applied Biosystems and Celera Genomics. Celera Diagnostics, a joint venture formed by Applied Biosystems and Celera Genomics in April 2001, is focused on the discovery, development, and commercialization of novel diagnostic products. A description of this business segment and developments during our 2003 fiscal year is set forth below in this Item 1 under the heading "Celera Diagnostics, a Joint Venture between Applied Biosystems and Celera Genomics." Information about the risk factors associated with our business segments is set forth below in Item 5 of Part II of this report under the headings "Market for Registrant's Common Equity and Related Stockholder Matters - Forward Looking Statements and Risk Factors." We maintain a corporate staff to provide accounting, tax, treasury, legal, information technology, human resources, and other internal services for Applied Biosystems, Celera Genomics, and Celera Diagnostics.

IMPORTANT DISCLAIMER: By reading any of the material on this website you agree to our DISCLAIMER: The Magi Society, Magi Astrologers Worldwide Corporation make no claims whatsoever concerning the validity of the information provided herein, and will not be held liable for any use thereof. No information or opinion expressed here is a solicitation to buy or sell securities, bonds, real estate, commodities, options, futures or any financial instruments whatsoever.